这三种厕所检测健康技术将在美国进行临床测试, 以色列和日本

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. 该公司已申请了一系列三项专利，涵盖其医用厕所传感器的元件.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, 欧洲, 日本和中国.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense 的技术可以识别胃肠道的血液来源.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

OutSense 首席执行官 Yfat Scialom 表示, who predicts that “随着数字医学的爆炸式增长, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, 炎症性肠病和尿路感染.

Its solution consists of a multispectral optical sensor, 光源和包含 WiFi 连接的自主筛选设备. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. 从血液样本中获得的信息, 结合从出血到排泄的时间的附加分析, 提供出血病理学的详细信息. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense 宣布 CommuniCare, 一家大型医疗保健公司，拥有超过 90 healthcare facilities in the US, 将于今年开始试点其技术. 除了这个试点, OutSense also plans to conduct clinical trials in Israel and Japan.